To understand the full relationship between brain activity and behavior, scientists have needed a way to map this relationship for all of the neurons across a whole brain-;a so far insurmountable challenge.
CC-98633 by Bristol-Myers Squibb for Relapsed Multiple Myeloma: Likelihood of Approval
CC-98633 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Relapsed Multiple Myeloma.